BHC Soars as Carl Icahn Takes Significant Stake in Bausch Health

Author's Avatar
3 days ago
Article's Main Image

Key Highlights:

  • Billionaire Carl Icahn (Trades, Portfolio) reveals a significant 34% economic interest in Bausch Health (BHC, Financial).
  • Analysts provide a one-year price target average of $8.25, suggesting substantial upside potential.
  • The GF Value estimate for Bausch Health indicates a promising future valuation increase.

Carl Icahn (Trades, Portfolio)'s Strategic Move

In a notable development, Bausch Health (BHC) shares leaped by 13% during premarket trading following the revelation of billionaire investor Carl Icahn (Trades, Portfolio)'s substantial economic interest. His involvement comprises a 9.4% ownership stake and equity swap agreements covering a substantial 24.6% of shares, which are set to mature in February 2028. Investors are viewing this as a strong vote of confidence in the company's prospects.

Wall Street Analysts' Forecast

1914665809783975936.png

The one-year price targets provided by six analysts for Bausch Health Companies Inc (BHC, Financial) suggest an average target price of $8.25. This projection spans a high estimate of $12.00 and a low of $5.00, indicating a potential upside of 74.79% from the present market price of $4.72. For more comprehensive forecast data, visit the Bausch Health Companies Inc (BHC) Forecast page.

Analyst Recommendations

According to the consensus from six brokerage firms, Bausch Health Companies Inc (BHC, Financial) holds an average recommendation of 3.2, suggesting a "Hold" status. The recommendation scale ranges from 1 (Strong Buy) to 5 (Sell), providing insights into the market's sentiment regarding the stock's potential.

GF Value Insight

Per GuruFocus estimates, the projected GF Value for Bausch Health Companies Inc (BHC, Financial) in the next year stands at $9.23. This estimate hints at a 95.55% upside potential from the current trading price of $4.72. The GF Value is a crucial metric, calculated based on historical market multiples, previous business growth, and anticipated future performance. Investors can explore more detailed valuation metrics on the Bausch Health Companies Inc (BHC) Summary page.

Also check out:

    Disclosures

    I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.